Orchestra BioMed Holdings, Inc. Increase (Decrease) in Contract with Customer, Liability
Orchestra BioMed Holdings, Inc. (OBIO) reported Increase (Decrease) in Contract with Customer, Liability of -$15.43 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$13.31M.
- Orchestra BioMed Holdings, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$721.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was -$667.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was -$732.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$15.43M.
- Orchestra BioMed Holdings, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$2.00M.
- Orchestra BioMed Holdings, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$2.11M.
- Orchestra BioMed Holdings, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was -$2.86M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$13.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$14.03M derived: sum of 2 quarters · filed 2026-03-12 | -$14.70M derived: sum of 3 quarters · filed 2026-08-10 | -$15.43M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$721.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.39M derived: sum of 2 quarters · filed 2026-08-10 | -$2.12M 10-Q · filed 2025-11-10 | -$2.20M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$667.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.40M 10-Q · filed 2026-08-10 | -$1.48M derived: sum of 3 quarters · filed 2026-08-10 | -$2.28M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$732.00K 10-Q · filed 2026-05-12 | -$809.00K derived: sum of 2 quarters · filed 2026-05-12 | -$1.61M derived: sum of 3 quarters · filed 2026-05-12 | -$2.24M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$880.00K derived: sum of 2 quarters · filed 2026-03-12 | -$1.51M derived: sum of 3 quarters · filed 2026-03-12 | -$2.00M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$803.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.43M derived: sum of 2 quarters · filed 2025-11-10 | -$1.93M 10-Q · filed 2025-11-10 | -$2.02M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$628.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.13M 10-Q · filed 2025-08-12 | -$1.21M derived: sum of 3 quarters · filed 2025-08-12 | -$1.48M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$497.00K 10-Q · filed 2025-05-12 | -$585.00K derived: sum of 2 quarters · filed 2025-05-12 | -$856.00K derived: sum of 3 quarters · filed 2025-05-12 | -$1.58M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$359.00K derived: sum of 2 quarters · filed 2025-03-31 | -$1.09M derived: sum of 3 quarters · filed 2025-03-31 | -$2.11M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$999.00K derived: sum of 2 quarters · filed 2024-11-12 | -$2.02M 10-Q · filed 2024-11-12 | -$2.95M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$728.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$1.75M 10-Q · filed 2024-08-12 | -$2.68M derived: sum of 3 quarters · filed 2024-08-12 | -$3.66M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$1.02M 10-Q · filed 2024-05-13 | -$1.95M derived: sum of 2 quarters · filed 2024-05-13 | -$2.94M derived: sum of 3 quarters · filed 2024-05-13 | -$3.17M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$931.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$1.92M derived: sum of 2 quarters · filed 2024-03-27 | -$2.15M derived: sum of 3 quarters · filed 2024-03-27 | -$2.86M 10-K · filed 2024-03-27 |
| 2022-09-30 | -$986.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$1.22M derived: sum of 2 quarters · filed 2023-11-13 | -$1.93M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$945.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$716.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |